People: Lexicon Pharmaceuticals, Inc. (LXRX.O)

LXRX.O on Consolidated Issue listed on NASDAQ Global Market

1.68USD
9 Feb 2010
Price Change (% chg)

$-0.03 (-1.75%)
Prev Close
$1.68
Open
--
Day's High
$1.76
Day's Low
$1.65
Volume
537,249
Avg. Vol
644,511
52-wk High
$3.78
52-wk Low
$0.81

view people for:

Wade, Jeffrey 

Brief Biography

Mr. Jeffrey L. Wade, J.D. is Executive Vice President and general counsel of Lexicon Pharmaceuticals since February 2000 and was senior vice president and chief financial officer from January 1999 to February 2000. From 1988 through December 1998, Mr. Wade was a corporate securities and finance attorney with the law firm of Andrews & Kurth L.L.P., for the last two years as a partner, where he represented companies in the biotechnology, information technology and energy industries. Mr. Wade is a member of the boards of directors of the Texas Healthcare and Bioscience Institute, the Texas Institute for Genomic Medicine and the Texas Life Science Center for Innovation and Commercialization. He received his B.A. and J.D. from the University of Texas.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
338,333 -- 321,522 690,424

Options Compensation

  Quantity Market Value
Excercisable 685,567 583,625.00
Unexercisable 110,933 --
Excercised 7,500 59,160.00
Name Fiscal Year Total
Barker, Samuel --
Sands, Arthur 1,534,810
Zambrowicz, Brian 886,418
Wade, Jeffrey 690,424
Main, Alan 620,498
Brown, Philip --
As Of 30 Dec 2008
view people for: